X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (149788) 149788
Newspaper Article (25490) 25490
Newsletter (12179) 12179
Magazine Article (866) 866
Book Chapter (428) 428
Web Resource (376) 376
Trade Publication Article (353) 353
Book / eBook (268) 268
Transcript (241) 241
Government Document (131) 131
Conference Proceeding (45) 45
Dissertation (41) 41
Reference (30) 30
Book Review (22) 22
Streaming Video (16) 16
Publication (10) 10
Journal / eJournal (6) 6
Paper (4) 4
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (104311) 104311
male (56917) 56917
female (54957) 54957
lung cancer (44231) 44231
oncology (41646) 41646
middle aged (38803) 38803
cancer (35752) 35752
animals (31823) 31823
aged (31739) 31739
research (29957) 29957
adult (29926) 29926
chemotherapy (27054) 27054
care and treatment (26166) 26166
respiratory system (23296) 23296
lung neoplasms - drug therapy (20303) 20303
lung diseases (19805) 19805
cancer therapies (18764) 18764
lung cancer, non-small cell (17405) 17405
metastasis (16637) 16637
health aspects (16350) 16350
tumors (16329) 16329
mice (16167) 16167
treatment outcome (16018) 16018
drug therapy (15621) 15621
patients (15170) 15170
analysis (14453) 14453
lungs (14010) 14010
medical research (13509) 13509
lung neoplasms - pathology (13168) 13168
clinical trials (12579) 12579
prognosis (12484) 12484
apoptosis (11863) 11863
carcinoma, non-small-cell lung - drug therapy (11438) 11438
mutation (11179) 11179
pharmacology & pharmacy (11153) 11153
expression (11143) 11143
medicine (10995) 10995
inflammation (10933) 10933
proteins (10909) 10909
risk factors (10505) 10505
lung diseases, obstructive (10295) 10295
studies (10106) 10106
lung-cancer (10102) 10102
therapy (10038) 10038
aged, 80 and over (9682) 9682
asthma (9529) 9529
oncology, experimental (9468) 9468
mortality (9411) 9411
cell lung-cancer (9234) 9234
diagnosis (9123) 9123
immunology (9051) 9051
antineoplastic combined chemotherapy protocols - therapeutic use (8994) 8994
genetic aspects (8935) 8935
gene expression (8907) 8907
disease (8873) 8873
surgery (8841) 8841
survival (8689) 8689
cell line, tumor (8656) 8656
lung - pathology (8529) 8529
immunotherapy (8448) 8448
respiratory tract diseases (8400) 8400
kinases (8389) 8389
disease models, animal (8309) 8309
medicine & public health (8272) 8272
retrospective studies (8206) 8206
research article (8103) 8103
lung (7972) 7972
cell biology (7927) 7927
antineoplastic agents - therapeutic use (7890) 7890
development and progression (7652) 7652
medical prognosis (7217) 7217
chronic obstructive pulmonary disease (7206) 7206
drugs (7193) 7193
medicine, experimental (7193) 7193
lung neoplasms - genetics (7001) 7001
carcinoma, non-small-cell lung - pathology (6990) 6990
breast cancer (6970) 6970
pharmaceutical industry (6904) 6904
adolescent (6840) 6840
lung - drug effects (6825) 6825
multidisciplinary sciences (6694) 6694
time factors (6454) 6454
medicine, general & internal (6365) 6365
medicine, research & experimental (6110) 6110
lung cancer, small cell (6109) 6109
biomarkers (5963) 5963
neoplasm staging (5944) 5944
biochemistry & molecular biology (5835) 5835
abridged index medicus (5622) 5622
pneumonia (5616) 5616
pediatrics (5586) 5586
rats (5582) 5582
child (5476) 5476
usage (5433) 5433
infections (5405) 5405
science (5321) 5321
non-small cell lung cancer (5278) 5278
disease progression (5271) 5271
drug dosages (5271) 5271
signal transduction (5234) 5234
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (131) 131
Online Resources - Online (50) 50
Collection Dvlpm't (Acquisitions) - Vendor file (18) 18
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (10) 10
West Park Healthcare Centre - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
St. Michael's Hospital - Stacks (4) 4
Scarborough Hospital - General (3) 3
Providence Healthcare - Reference (2) 2
Providence Healthcare - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Gerstein Science - Course Reserves (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Periodical Stacks (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (183922) 183922
German (1664) 1664
Japanese (1443) 1443
French (1441) 1441
Chinese (897) 897
Russian (794) 794
Spanish (562) 562
Italian (460) 460
Polish (270) 270
Portuguese (228) 228
Dutch (130) 130
Romanian (77) 77
Danish (71) 71
Hungarian (65) 65
Norwegian (57) 57
Czech (55) 55
Korean (40) 40
Turkish (36) 36
Swedish (28) 28
Croatian (27) 27
Hebrew (25) 25
Serbian (18) 18
Ukrainian (18) 18
Bulgarian (17) 17
Slovak (15) 15
Lithuanian (9) 9
Finnish (8) 8
Slovenian (5) 5
Afrikaans (3) 3
Icelandic (3) 3
Arabic (2) 2
Bosnian (2) 2
Greek (2) 2
Urdu (2) 2
Hindi (1) 1
Indonesian (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pulmonary pharmacology & therapeutics, ISSN 1094-5539, 1997
Journal
Journal of aerosol medicine and pulmonary drug delivery, ISSN 1941-2711, 2008
Journal
Pulmonary pharmacology, ISSN 0952-0600, 1988
Journal
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 44, pp. 51 - 60
Highlights • Role of immune checkpoint inhibition in the management of key malignancies. • Description of rates of immune-related adverse events and timing of... 
Hematology, Oncology and Palliative Medicine | Pembrolizumab | Immune-related adverse events | Renal cancer | Ipilimumab | Nivolumab | Lung cancer | Melanoma | Immune-checkpoint inhibitors | OPEN-LABEL | SINGLE-ARM | ANTI-CTLA-4 ANTIBODY | METASTATIC MELANOMA | ONCOLOGY | ADVANCED MELANOMA | LONG-TERM SAFETY | MALIGNANT MESOTHELIOMA | ENTERIC NEUROPATHY | ADVERSE EVENTS | IPILIMUMAB RETREATMENT | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Antilymphocyte Serum - therapeutic use | Colitis - drug therapy | Carcinoma, Renal Cell - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Pituitary Diseases - chemically induced | Pituitary Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Neoplasms - drug therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Melanoma - drug therapy | Chemical and Drug Induced Liver Injury - drug therapy | Diarrhea - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Thyroiditis - drug therapy | Thyroiditis - chemically induced | Index Medicus
Journal Article
by Pons-Estel, Bernardo A and Bonfa, Eloisa and Soriano, Enrique R and Cardiel, Mario H and Izcovich, Ariel and Popoff, Federico and Criniti, Juan M and Vásquez, Gloria and Massardo, Loreto and Duarte, Margarita and Barile-Fabris, Leonor A and García, Mercedes A and Amigo, Mary-Carmen and Espada, Graciela and Catoggio, Luis J and Sato, Emilia Inoue and Levy, Roger A and Acevedo Vásquez, Eduardo M and Chacón-Díaz, Rosa and Galarza-Maldonado, Claudio M and Iglesias Gamarra, Antonio J and Molina, José Fernando and Neira, Oscar and Silva, Clóvis A and Vargas Peña, Andrea and Gómez-Puerta, José A and Scolnik, Marina and Pons-Estel, Guillermo J and Ugolini-Lopes, Michelle R and Savio, Verónica and Drenkard, Cristina and Alvarellos, Alejandro J and Ugarte-Gil, Manuel F and Babini, Alejandra and Cavalcanti, André and Cardoso Linhares, Fernanda Athayde and Haye Salinas, Maria Jezabel and Fuentes-Silva, Yurilis J and Montandon de Oliveira e Silva, Ana Carolina and Eraso Garnica, Ruth M and Herrera Uribe, Sebastián and Gómez-Martín, Diana and Robaina Sevrini, Ricardo and Quintana, Rosana M and Gordon, Sergio and Fragoso-Loyo, Hilda and Rosario, Violeta and Saurit, Verónica and Appenzeller, Simone and dos Reis Neto, Edgard Torres and Cieza, Jorge and González Naranjo, Luis A and González Bello, Yelitza C and Collado, María Victoria and Sarano, Judith and Retamozo, Soledad and Sattler, María E and Gamboa-Cárdenas, Rocio V and Cairoli, Ernesto and Conti, Silvana M and Amezcua-Guerra, Luis M and Silveira, Luis H and Borba, Eduardo F and Pera, Mariana A and Alba Moreyra, Paula B and Arturi, Valeria and Berbotto, Guillermo A and Gerling, Cristian and Gobbi, Carla A and Gervasoni, Viviana L and Scherbarth, Hugo R and Brenol, João C Tavares and Cavalcanti, Fernando and Costallat, Lilian T Lavras and Da Silva, Nilzio A and Monticielo, Odirlei A and Seguro, Luciana Parente Costa and Xavier, Ricardo M and Llanos, Carolina and Montúfar Guardado, Rubén A and Garcia de la Torre, Ignacio and Pineda, Carlos and Portela Hernández, Margarita and Danza, Alvaro and Guibert-Toledano, Marlene and Reyes, Gil Llerena and Acosta Colman, Maria Isabel and Aquino, Alicia M and Mora-Trujillo, Claudia S and Muñoz-Louis, Roberto and García Valladares, Ignacio and Orozco, María Celeste and Burgos, Paula I and Betancur, Graciela V and Alarcón, Graciela S and Grp Latino Amer Estudio Lupus and Pan-Amer League Assoc Rheumatology and Grupo Latino Americano de Estudio del Lupus (GLADEL) and Pan-American League of Associations of Rheumatology (PANLAR)
Annals of the Rheumatic Diseases, ISSN 0003-4967, 11/2018, Volume 77, Issue 11, pp. 1549 - 1557
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 2018, Volume 24, Issue 12, pp. 1339.e1 - 1339.e5
...) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing... 
Listeria monocytogenes | Listeriosis | Pleural effusion | Immunosuppression | Pneumonia | INFECTIOUS DISEASES | MANAGEMENT | SERIES | SURVEILLANCE | EFFUSION | MICROBIOLOGY | CENTRAL-NERVOUS-SYSTEM | Listeriosis - drug therapy | Sepsis - etiology | Lung Diseases - microbiology | Humans | Middle Aged | Pneumonia, Bacterial - etiology | Male | Lung Diseases - drug therapy | Lung Diseases - etiology | Empyema, Pleural - epidemiology | Listeriosis - epidemiology | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Pleuropneumonia - epidemiology | Aged, 80 and over | Adult | Female | Respiratory Tract Infections - etiology | Retrospective Studies | Pleuropneumonia - drug therapy | Pleuropneumonia - etiology | Pneumonia, Bacterial - microbiology | Listeriosis - complications | Empyema, Pleural - microbiology | Sepsis - epidemiology | Listeria monocytogenes - isolation & purification | Respiratory Tract Infections - drug therapy | Pleuropneumonia - microbiology | Pneumonia, Bacterial - epidemiology | Empyema, Pleural - drug therapy | Listeriosis - microbiology | Pneumonia, Bacterial - drug therapy | Aged | Respiratory Tract Infections - epidemiology | Empyema, Pleural - etiology | Lung Diseases - epidemiology | Sepsis - microbiology | Listeria monocytogenes - drug effects | Pneumonia, Bacterial/etiology | Sepsis/drug therapy | Lung Diseases/epidemiology | Empyema, Pleural/epidemiology | Sepsis/microbiology | Listeriosis/drug therapy | Pneumonia, Bacterial/epidemiology | Lung Diseases/microbiology | Lung Diseases/etiology | Life Sciences | Listeriosis/microbiology | Pneumonia, Bacterial/drug therapy | Sepsis/epidemiology | Pleuropneumonia/epidemiology | Pleuropneumonia/etiology | Respiratory Tract Infections/drug therapy | Lung Diseases/drug therapy | Empyema, Pleural/drug therapy | Listeria monocytogenes/isolation & purification | Pleuropneumonia/drug therapy | Listeria monocytogenes/drug effects | Respiratory Tract Infections/epidemiology | Pleuropneumonia/microbiology | Bacteriology | Human health and pathology | Microbiology and Parasitology | Infectious diseases | Respiratory Tract Infections/etiology | Respiratory Tract Infections/microbiology | Listeriosis/complications | Empyema, Pleural/etiology | Empyema, Pleural/microbiology | Listeriosis/epidemiology | Pneumonia, Bacterial/microbiology | Anti-Bacterial Agents/therapeutic use | Sepsis/etiology
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 18, pp. 1671 - 1680
BACKGROUND The benefits of triple therapy for chronic obstructive pulmonary disease (COPD... 
MEDICINE, GENERAL & INTERNAL | OBSTRUCTIVE PULMONARY-DISEASE | IMPACT | PARALLEL-GROUP | DOUBLE-BLIND | TIOTROPIUM | RANDOMIZED CONTROLLED-TRIAL | FLUTICASONE PROPIONATE/SALMETEROL | SALMETEROL | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Hospitalization - statistics & numerical data | Male | Dyspnea - etiology | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - complications | Muscarinic Antagonists - administration & dosage | Androstadienes - administration & dosage | Intention to Treat Analysis | Quality of Life | Dyspnea - drug therapy | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Treatment outcome | Lung diseases, Obstructive | Care and treatment | Usage | Analysis | Diagnosis | Inhalers | Pneumonia | Acetylcholine receptors (muscarinic) | Glucocorticoids | Lung diseases | Critical care | Fluticasone | Patients | Quality of life | Medicine | Hospitals | Obstructive lung disease | Population | Chronic obstructive pulmonary disease | Drug dosages | Life Sciences | Human health and pathology | Pulmonology and respiratory tract
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 26, pp. 2455 - 2465
Antibodies to PD-1 protein and to one of its ligands, PD-L1, have shown antitumor activity. Unleashing T cells from inhibitory signals may be a strategy to... 
MEDICINE, GENERAL & INTERNAL | IMMUNOTHERAPY | GUIDELINES | B7 FAMILY | B7-H1 | CTLA-4 | LIGAND | BLOCKADE | CLINICAL ACTIVITY | PHASE-I | PD-1 | Neoplasms - metabolism | Humans | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Dose-Response Relationship, Drug | Pancreatic Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Female | Carcinoma, Renal Cell - drug therapy | Ovarian Neoplasms - drug therapy | Programmed Cell Death 1 Receptor - metabolism | Stomach Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Antibodies, Monoclonal - administration & dosage | Melanoma - drug therapy | Nivolumab | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Intravenous administration | Kidneys | Immune response | Disease | PD-1 protein | Tumor cells | Colorectal carcinoma | Body weight | Melanoma | Lymphocytes T | Breast cancer | Stomach cancer | Patients | Ovarian cancer | Lungs | Pancreatic cancer | PD-L1 protein | Antitumor activity | Ligands | Autoimmune diseases | Gastric cancer | Clear cell-type renal cell carcinoma | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article